Details about Francesco Saverio Mennini

Access statistics for papers by Francesco Saverio Mennini.

Last updated 2024-02-08. Update your information in the RePEc Author Service.

Short-id: pme934

Working Papers

2022

1. Approaches to Estimating Indirect Costs in Healthcare: Motivations for Choice
   MPRA Paper, University Library of Munich, Germany View citations (1)

2016

2. Early treatment in HCV: is it a cost-effective option from the Italian perspective?
   CEIS Research Paper, Tor Vergata University, CEIS View citations (2)

2015

3. Cost of poor adherence to anti-hypertensive therapy in five European countries
   Post-Print, HAL View citations (3)
   See also Journal Article Cost of poor adherence to anti-hypertensive therapy in five European countries, The European Journal of Health Economics, Springer (2015) View citations (2) (2015)
4. Treatment Plan Comparison in Obstructive Respiratory Disorders: an Observational Study of Doxofylline vs. Theophylline in the Marche Region
   CEIS Research Paper, Tor Vergata University, CEIS

2014

5. Direct and Indirect Cost of Diabetes in Italy: a Prevalence Probabilistic Approach
   CEIS Research Paper, Tor Vergata University, CEIS
   See also Journal Article The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach, The European Journal of Health Economics, Springer (2016) View citations (10) (2016)
6. Health Policy Model: Long-term Predictive Results Associated With The Management Of HCV-Induced Diseases In Italy
   CEIS Research Paper, Tor Vergata University, CEIS View citations (3)

2013

7. Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe
   CEIS Research Paper, Tor Vergata University, CEIS
8. Economic effects of treatment of chronic kidney disease with low-protein diet
   CEIS Research Paper, Tor Vergata University, CEIS View citations (1)

Journal Articles

2023

1. COVID-19 Outbreak: A Call to Arms for the World Healthcare Systems
   IJERPH, 2023, 20, (24), 1-3
2. Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis
   The European Journal of Health Economics, 2023, 24, (1), 75-80

2022

3. Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
   Applied Health Economics and Health Policy, 2022, 20, (1), 133-143
4. Health and Economic Impact of Atrial Fibrillation of Workers in Italy: Social Security Benefits
   IJERPH, 2022, 19, (3), 1-8

2021

5. An Analysis of the Social and Economic Costs of Breast Cancer in Italy
   IJERPH, 2021, 18, (17), 1-12
6. Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
   Health Economics Review, 2021, 11, (1), 1-10
7. Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data
   The European Journal of Health Economics, 2021, 22, (9), 1371-1379

2019

8. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data
   PharmacoEconomics, 2019, 37, (2), 255-266
9. Economic burden of HPV9-related diseases: a real-world cost analysis from Italy
   The European Journal of Health Economics, 2019, 20, (6), 829-840 View citations (1)
10. Il personale del Servizio Sanitario Nazionale - evoluzione e prospettive nella programmazione sanitaria
    MECOSAN, 2019, 2019/110, (110), 9-43

2017

11. Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory
    Quality & Quantity: International Journal of Methodology, 2017, 51, (3), 1261-1276
12. Does regional belonging explain the similarities in the expenditure determinants of Italian healthcare deliveries?
    Economic Analysis and Policy, 2017, 55, (C), 47-56 View citations (1)
13. Erratum to: Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory
    Quality & Quantity: International Journal of Methodology, 2017, 51, (3), 1277-1278
14. The perception of corruption in health: AutoCM methods for an international comparison
    Quality & Quantity: International Journal of Methodology, 2017, 51, (1), 459-477 View citations (2)

2016

15. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach
    The European Journal of Health Economics, 2016, 17, (2), 139-147 View citations (10)
    See also Working Paper Direct and Indirect Cost of Diabetes in Italy: a Prevalence Probabilistic Approach, CEIS Research Paper (2014) (2014)

2015

16. Cost of poor adherence to anti-hypertensive therapy in five European countries
    The European Journal of Health Economics, 2015, 16, (1), 65-72 View citations (2)
    See also Working Paper Cost of poor adherence to anti-hypertensive therapy in five European countries, Post-Print (2015) View citations (3) (2015)
17. Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country
    The European Journal of Health Economics, 2015, 16, (8), 909-911 View citations (2)

2012

18. Economic Burden of Human Papillomavirus-Related Diseases in Italy
    PLOS ONE, 2012, 7, (11), 1-15 View citations (3)

2005

19. Dinamiche determinanti del settore farmaceutico in Europa
    L'industria, 2005, (1), 103-118

2003

20. Strategie e performance delle grandi aziende farmaceutiche in Italia (1979-2001)
    L'industria, 2003, (2), 333-350
21. The Welfare States in a United Europe
    European Political Economy Review, 2003, 1, (Spring), 40-55 View citations (11)